Renal osteodystrophy

Common Name(s)

Renal osteodystrophy

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Renal osteodystrophy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Renal osteodystrophy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Renal osteodystrophy" returned 86 free, full-text research articles on human participants. First 3 results:

Renal osteodystrophy in the obesity era: Is metabolic syndrome relevant?
 

Author(s): Janaina Da Silva Martins, João Henrique Castro, Nestor A Sainz Rueda, Luciene Machado Dos Reis, Vanda Jorgetti, Rosa Maria Affonso Moysés, Jacqueline Teixeira Caramori

Journal:

 

Observational studies have shown a beneficial effect of obesity on bone health; however, most of those studies were not based on bone biopsies. Metabolic syndrome (MetS) could have an effect on bone remodeling. However, there are no data on the effects of MetS in the presence of renal ...

Last Updated: 18 Jul 2017

Go To URL
Association of vitamin D receptor gene polymorphisms with end-stage renal disease and the development of high-turnover renal osteodystrophy in a Chinese population.
 

Author(s): L Y Wang, P Zhang, H F Wang, Z W Qin, K B Wei, X A Lv

Journal:

 

Two single nucleotide polymorphisms (SNPs; TaqI and ApaI) in the vitamin D receptor (VDR) gene have been identified as risk factors for the progression of end-stage renal disease (ESRD). The purpose of our study was to confirm the reported association of these two SNPs with ESRD risk ...

Last Updated: 21 Jun 2016

Go To URL
Bone Canopies in Pediatric Renal Osteodystrophy.
 

Author(s): Renata C Pereira, Thomas L Andersen, Peter A Friedman, Navdeep Tumber, Isidro B Salusky, Katherine Wesseling-Perry

Journal:

 

Pediatric renal osteodystrophy (ROD) is characterized by changes in bone turnover, mineralization, and volume that are brought about by alterations in bone resorption and formation. The resorptive and formative surfaces on the cancellous bone are separated from the marrow cavity by ...

Last Updated: 6 Apr 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Renal osteodystrophy" returned 22 free, full-text review articles on human participants. First 3 results:

Recent advances in the noninvasive diagnosis of renal osteodystrophy.
 

Author(s): Ranjani N Moorthi, Sharon M Moe

Journal: Kidney Int.. 2013 Nov;84(5):886-94.

 

Chronic kidney disease-mineral and bone disorder (CKD-MBD) is the term used to describe a constellation of biochemical abnormalities, bone disturbances that may lead to fractures, and extraskeletal calcification in soft tissues and arteries seen in CKD. This review focuses on the ...

Last Updated: 31 Oct 2013

Go To URL
Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality.
 

Author(s): Adriana Dusso, Maria Vittoria Arcidiacono, Jing Yang, Masanori Tokumoto

Journal: J. Steroid Biochem. Mol. Biol.. 2010 Jul;121(1-2):193-8.

 

In the course of kidney disease, the progressive loss of renal capacity to maintain normal serum levels of 1,25-dihydroxyvitamin D (1,25(OH)2D) is a main contributor to parathyroid hyperplasia and high serum PTH. High PTH causes mineral and skeletal abnormalities predisposing to ectopic ...

Last Updated: 19 Jul 2010

Go To URL
Effects of treatment of renal osteodystrophy on bone histology.
 

Author(s): Hartmut H Malluche, Hanna Mawad, Marie-Claude Monier-Faugere

Journal: Clin J Am Soc Nephrol. 2008 Nov;3 Suppl 3():S157-63.

 

Renal osteodystrophy is characterized by abnormalities in bone turnover, mineralization, and bone volume. The effects of treatment modalities for renal osteodystrophy on bone should be analyzed with respect to these abnormalities. The major treatment modalities for renal osteodystrophy ...

Last Updated: 7 Nov 2008

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Systematic Study of Parameters of Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD)
 

Status: Recruiting

Condition Summary: Renal Osteodystrophy

 

Last Updated: 19 Aug 2016

Go to URL
Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency
 

Status: Recruiting

Condition Summary: Chronic Renal Insufficiency; Renal Osteodystrophy

 

Last Updated: 29 Nov 2016

Go to URL
Renal Osteodystrophy: An Individual Management Approach
 

Status: Recruiting

Condition Summary: Kidney Failure, Chronic

 

Last Updated: 2 May 2017

Go to URL